Aptose Biosciences Inc(NASDAQ:APTO) 
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1a/b clinical trial for the treatment of patients with relapsed or refra...
Website: http://www.aptose.com
Founded: 2014
Full Time Employees: 31
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-10-01
P
O 12.31
H 12.31
L 12.01
C 12.31
V 51,397
10EMA 12.31
20EMA 12.31
60EMA 12.31
120EMA 12.31
250EMA 12.31